Index of reports
> Cases with Incorrect Dose Administered (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Elmiron (Pentosan Polysulfate) where reactions include incorrect dose administered. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-02
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Hysterectomy, Incorrect Dose Administered, Adverse Event, Headache, Treatment Noncompliance, Sinusitis
Drug(s) suspected as cause:
Elmiron
Other drugs received by patient: Hydrocodone; Levofloxacin; Nasonex; Cymbalta; Tramadol HCL
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-23
Patient: female, weighing 77.1 kg (169.6 pounds)
Reactions: Gingivitis, Tinnitus, Dysphagia, Rash Papular, Incorrect Dose Administered, Dysgeusia, Dysphonia, Oral Pain, DRY Mouth, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-01-01
End date: 2011-01-01
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Risperdal
Dosage: 1/2 of 0.25mg tablet
Administration route: Oral
End date: 2012-01-01
Risperdal
Administration route: Oral
Start date: 2011-01-01
Protonix
Protonix
End date: 2011-12-23
Elmiron
Administration route: Oral
Start date: 2011-10-21
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastric Disorder
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Risperdal
Administration route: Oral
Start date: 2011-06-28
Elmiron
Administration route: Oral
Start date: 2011-10-12
Elmiron
Administration route: Oral
Start date: 2011-10-21
Elmiron
Administration route: Oral
Indication: Bladder Pain
Start date: 2011-10-12
Risperdal
Dosage: 1/4 of 0.25mg tablet
Administration route: Oral
Indication: Anxiety
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Start date: 2011-01-01
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastrooesophageal Reflux Disease
End date: 2011-12-23
Other drugs received by patient: Atenolol; Tenormin; Prilosec; Estradiol; Valium; Valium; Valium; Pepcid
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-02
Patient: female, weighing 77.1 kg (169.6 pounds)
Reactions: Tinnitus, Dysphagia, Gingivitis, Incorrect Dose Administered, Rash Papular, Dysgeusia, Oral Pain, Dysphonia, DRY Mouth, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2011-01-01
Risperdal
Dosage: 1/2 of 0.25mg tablet
Administration route: Oral
End date: 2012-01-01
Elmiron
Administration route: Oral
Start date: 2011-10-12
Elmiron
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-10-21
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Start date: 2011-01-01
Risperdal
Administration route: Oral
Indication: Anxiety
Start date: 2011-06-28
Elmiron
Administration route: Oral
Indication: Bladder Pain
Start date: 2011-10-21
Protonix
Indication: Gastric Disorder
End date: 2011-12-23
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Protonix
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Elmiron
Administration route: Oral
Start date: 2011-10-12
Risperdal
Dosage: 1/4 of 0.25mg tablet
Administration route: Oral
Protonix
End date: 2011-12-23
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Start date: 2011-01-01
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastrooesophageal Reflux Disease
Other drugs received by patient: Atenolol; Valium; Estradiol; Tenormin; Valium; Valium; Prilosec; Pepcid
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-13
Patient: female, weighing 76.7 kg (168.7 pounds)
Reactions: Tinnitus, Gingivitis, Rash Papular, Incorrect Dose Administered, Dysgeusia, Dysphonia, Oral Pain, DRY Mouth, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Risperdal
Administration route: Oral
Start date: 2011-06-28
Risperdal
Dosage: 1/4 of 0.25mg tablet
Administration route: Oral
Indication: Anxiety
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Risperdal
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastrooesophageal Reflux Disease
End date: 2011-12-23
Elmiron
Administration route: Oral
Start date: 2011-10-21
Elmiron
Administration route: Oral
Elmiron
Administration route: Oral
Elmiron
Administration route: Oral
Start date: 2011-10-21
Risperdal
Dosage: 1/2 of 0.25mg tablet
Administration route: Oral
End date: 2012-01-01
Protonix
Protonix
End date: 2011-12-23
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Indication: Bladder Pain
Start date: 2011-01-01
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Start date: 2011-01-01
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-01-01
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Protonix
Indication: Gastric Disorder
Other drugs received by patient: Valium; Valium; Valium; Atenolol
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-27
Patient: female, weighing 76.2 kg (167.6 pounds)
Reactions: Dysgeusia, Tinnitus, Oral Pain, Dysphonia, DRY Mouth, Incorrect Dose Administered, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Protonix
End date: 2011-12-23
Risperdal
Dosage: 1/2 of 0.25mg tablet
Administration route: Oral
Indication: Anxiety
End date: 2012-01-01
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastric Disorder
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-01-01
Risperdal
Dosage: 1/4 of 0.25mg tablet
Administration route: Oral
Risperdal
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastrooesophageal Reflux Disease
Protonix
End date: 2011-12-23
Other drugs received by patient: Valium; Valium; Atenolol; Valium
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-07
Patient: female, weighing 76.2 kg (167.6 pounds)
Reactions: Dysgeusia, Tinnitus, Dysphonia, Oral Pain, Incorrect Dose Administered, DRY Mouth, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Protonix
Indication: Gastric Disorder
Protonix
End date: 2011-12-23
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Risperdal
Dosage: 1/2 of 0.25mg tablet
Administration route: Oral
Indication: Anxiety
End date: 2012-01-01
Risperdal
Dosage: 1/4 of 0.25mg tablet
Administration route: Oral
Protonix
Indication: Gastrooesophageal Reflux Disease
Elmiron
Administration route: Oral
Protonix
End date: 2011-12-23
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Risperdal
Administration route: Oral
Start date: 2011-01-01
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-01-01
Other drugs received by patient: Valium; Atenolol; Valium; Valium
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-31
Patient: female, weighing 76.2 kg (167.6 pounds)
Reactions: Dysgeusia, Tinnitus, Oral Pain, Dysphonia, Incorrect Dose Administered, DRY Mouth, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Elmiron
Dosage: 2 100mg capsules in the night
Administration route: Oral
Start date: 2011-01-01
Protonix
End date: 2011-12-23
Elmiron
Administration route: Oral
Risperdal
Dosage: 1/2 of 0.25mg tablet
Administration route: Oral
Indication: Anxiety
End date: 2012-01-01
Risperdal
Dosage: 1/4 of 0.25mg tablet
Administration route: Oral
Protonix
End date: 2011-12-23
Protonix
Indication: Gastric Disorder
Elmiron
Dosage: 100mg capsule in the morning
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-01-01
Risperdal
Administration route: Oral
Start date: 2011-01-01
Protonix
Indication: Gastrooesophageal Reflux Disease
Other drugs received by patient: Valium; Valium; Valium; Atenolol
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-13
Patient: female, weighing 76.2 kg (167.6 pounds)
Reactions: Dysgeusia, Tinnitus, Dysphonia, Incorrect Dose Administered
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Indication: Cystitis Interstitial
Protonix
Indication: Gastric Disorder
End date: 2011-12-23
Elmiron
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Other drugs received by patient: Valium; Atenolol; Risperidone; Valium
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2011-11-18
Patient: female, weighing 59.0 kg (129.7 pounds)
Reactions: Tinnitus, Incorrect Dose Administered, Vaginal Infection, Intentional Drug Misuse, Micturition Urgency, Gastric Disorder
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2010-12-01
End date: 2011-06-01
Elmiron
Administration route: Oral
Start date: 2011-06-01
Other drugs received by patient: Synthroid; Nexium; Hydrodiuril
Possible Elmiron side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-11
Patient: female, weighing 87.1 kg (191.6 pounds)
Reactions: Intraocular Pressure Increased, Incorrect Dose Administered
Drug(s) suspected as cause:
Elmiron
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2011-07-01
Oxybutynin
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2004-01-01
End date: 2011-07-01
Other drugs received by patient: Timolol Maleate
|